what happens if you stop taking glp-1 when a medication? Real-world care looks different than clinical trials. A new Cleveland Clinic study looked at nearly 8,000 patients and found stopping GLP-1 medications Woman shares journey of weight
Description
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining increasing attention as first-line agents for the treatment of diabetes and obesity, and with their potential to improve the muscle mass and function, they provide new ideas for the treatment of sarcopenia

Conclusions Semaglutide and tirzepatide were not associated with an increased risk of acute pancreatitis versus placebo
Serena Williams says she has lost weight using GLP-1 medication

Strength training while on GLP-1 helps protect muscle

Although glucagon-like peptide-1 receptor agonist use may increase the risk for retained gastric contents in those undergoing endoscopic procedures, a 24-hour clear liquid diet may be “protective&rdquo
